IDEXX Laboratories Inc

IDXX

573.290USD

-2.430-0.42%

Close 03/26, 16:00（ET）Quotes delayed by 15 min

IDEXX Laboratories Inc's Score

Industry at a Glance

Industry Ranking

41 / 209

Overall Ranking

127 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive+

IDEXX Laboratories Inc Highlights

StrengthsRisks

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.56% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.30B.

Undervalued

The company’s latest PE is 43.70, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 81.21M shares, decreasing 0.84% quarter-over-quarter.

Held by Mairs and Power

Star Investor Mairs and Power holds 2.59K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.21.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

753.515

Target Price

+30.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of IDEXX Laboratories Inc is 8.18, ranking 43 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.09B, representing a year-over-year increase of 14.28%, while its net profit experienced a year-over-year increase of 14.82%.

Score

Industry at a Glance

Previous score

8.18

Change

0



Financials

7.36

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.28

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.04

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.70

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.52

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of IDEXX Laboratories Inc is 4.64, ranking 190 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 43.70, which is 44.99% below the recent high of 63.37 and 24.32% above the recent low of 33.08.

Score

Industry at a Glance

Previous score

4.64

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/209

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of IDEXX Laboratories Inc is 8.00, ranking 63 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 787.50, with a high of 850.00 and a low of 475.21.

Score

Industry at a Glance

Previous score

8.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of IDEXX Laboratories Inc is 6.72, ranking 101 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 640.46 and the support level at 536.67, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.50

Change

0.22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of IDEXX Laboratories Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 101.70%, representing a quarter-over-quarter increase of 4.63%. The largest institutional shareholder is The Vanguard, holding a total of 9.91M shares, representing 12.44% of shares outstanding, with 2.68% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.93M

+0.87%

BlackRock Institutional Trust Company, N.A.

5.24M

-1.23%

State Street Investment Management (US)

3.52M

-1.03%

Geode Capital Management, L.L.C.

2.50M

+1.35%

Fundsmith LLP

2.61M

-1.09%

Baron Capital Management, Inc.

Star Investors

1.88M

-7.31%

Invesco Capital Management (QQQ Trust)

1.79M

+6.84%

William Blair & Company, L.L.C. (Research)

1.03M

-4.51%

BlackRock Asset Management Ireland Limited

998.68K

-4.94%

Principal Global Investors (Equity)

1.32M

+16.67%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of IDEXX Laboratories Inc is 7.69, ranking 34 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.72. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

IDEXX Laboratories Inc

IDXX

7.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.64 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.48 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

West Pharmaceutical Services Inc

WST

8.26 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.12 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment